BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18702949)

  • 1. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
    Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
    J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC; Lopes C; Guimarães JT; Barros H
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in Saudi Arabia.
    Al-Nozha M; Al-Khadra A; Arafah MR; Al-Maatouq MA; Khalil MZ; Khan NB; Al-Mazrou YY; Al-Marzouki K; Al-Harthi SS; Abdullah M; Al-Shahid MS; Al-Mobeireek A; Nouh MS
    Saudi Med J; 2005 Dec; 26(12):1918-25. PubMed ID: 16380773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of metabolic syndrome (MS) in older adults.
    Cankurtaran M; Halil M; Yavuz BB; Dagli N; Oyan B; Ariogul S
    Arch Gerontol Geriatr; 2006; 42(1):35-45. PubMed ID: 16046242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-reactive protein levels correlates better to metabolic syndrome defined by International Diabetes Federation than by NCEP ATP III in men.
    Lin MS; Shih SR; Li HY; Chuang LM; Chang TC; Wei JN; Shieh GJ; Chien YF; Hua CH; Hwang JJ
    Diabetes Res Clin Pract; 2007 Aug; 77(2):286-92. PubMed ID: 17234298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.